Skip to content

Effect of Semi-vegetarian Diet in Inflammatory Bowel Disease Patients With Clinical Remission

Effect of Semi-vegetarian Diet in Inflammatory Bowel Disease Patients With Clinical Remission

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04835727
Enrollment
60
Registered
2021-04-08
Start date
2020-01-21
Completion date
2021-10-01
Last updated
2022-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calprotectin, Fecal Microbiota, Inflammatory Bowel Diseases, Vegetarian Diet

Keywords

Vegetarian diet, inflammatory bowel diseases

Brief summary

In the 21st century, the incidence of inflammatory bowel disease (IBD) globally increases. Higher incidence of IBD development may implicate that environmental factors played essential roles in IBD pathogenesis. One of the environmental factors is a westernized diet that contains a high amount of animal protein and a low amount of dietary fiber. This kind of diet can lead to gut microbial dysbiosis and increase susceptibility to IBD. A microbial dysbiosis pattern in IBD is a decrease in microbial diversity and the inversed ratio of local protective and pathologic bacteria. High animal protein was associated with an increased risk of IBD and increased risk of disease relapse meanwhile dietary fiber was associated with IBD risk reduction. A semi-vegetarian diet is a diet with high fiber and low red meat and processed food that may reduce inflammatory activity in IBD. The study in the semi-vegetarian diet in IBD activity is still limited. This study aimed to evaluate a semi-vegetarian diet's effect in maintaining IBD remission in disease quiescence patients.

Detailed description

This study is a prospective interventional cohort in clinically quiescence IBD patients in Siriraj Hospital, Mahidol University, Bangkok, Thailand. At enrollment, clinical information, dietary intake, inflammatory markers, and fecal microbiota will be recorded. Dietary intake will be assessed by an experienced nutritionist using pictures of food, a dietary questionnaire, and patient interviewing. The nutritionist advises the participants to consume a semi-vegetarian diet which includes high dietary fiber consumption and low red meat and processed food consumption. All patients will be required to send all pictures of food intake three days in 1 week before every visit, including two weekdays and one weekend. The dietary component will be analyzed using Nutrient calculation computer software INMUCAL-Nutrient V3 database NB1 (Institute of Nutrition, Mahidol University. Nakornpathom. 2013). The study will take 1 year including 6 visits (including baseline, 6th weeks, 18th week, 30th week, 42nd week, 54th week) for each patient. The primary outcome is the effect of increasing fiber diets and decreasing red meat and processed food on maintaining clinical remission in IBD. Secondary outcomes are the effect of modifying diet on change of inflammatory markers, microbiota, and quality of life.

Interventions

OTHERSemi-vegetarian diet and increase fiber consumption

All patients in this study will be advised by an experienced nutritionist to intake high fiber diets with a low intake of red meat and processed food.

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

This is a prospective interventional cohort study in patients with clinically quiescent IBD. At enrollment, clinical information, dietary intake, inflammatory markers, and fecal microbiota were recorded. Dietary intake was assessed by an experienced nutritionist using pictures of food, a dietary questionnaire, and patient interviewing. The nutritionist advised the participants to intake a semi-vegetarian diet and increase dietary fiber consumption. The changes in clinical symptoms, dietary intake, inflammatory markers, and fecal microbiota were recorded in each visit for 1 year.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients with Crohn's disease or Ulcerative colitis 2. Age ≥ 18 years old 3. Disease in remission at least 2weeks by following criteria Crohn's disease: Crohn's Disease Activity Index(CDAI) \< 150 Ulcerative colitis: Mayo Ulcerative Colitis Subscore ≤ 2 4. Prednisolone ≤ 15 mg/day for at least 1 month 5. Stable immunomodulator dosage at least 1 month 6. Stable biologic agent at least 2 months

Exclusion criteria

1. Patients with Ulcerative colitis with a history of proctocolectomy 2. Patients with Crohn's disease with bowel stricture 3. Patients with recently antibiotic usage within 1 month 4. Pregnant patients

Design outcomes

Primary

MeasureTime frameDescription
Rate of participants with clinical relapses1 yearEffect of semi-vegetarian food consumption on the rate of participants with clinical relapses assessed by Crohn's disease activity index for Crohn's disease and the clinical Mayo Score or partial Mayo Score for ulcerative colitis. The Crohn's disease activity index ranges from 0 to 1100, a higher score means a worse outcome, and clinical relapse is defined if the score is at least 150 points. The clinical Mayo Score for ulcerative colitis ranges from 0 to 9, a higher score means a worse outcome, and clinical relapse is defined if the score is at least 2 points.

Secondary

MeasureTime frameDescription
C-Reactive Protein (CRP)1 yearEffect of semi-vegetarian food consumption on inflammatory markers levels including serum CRP
fecal calprotectin level1 yearEffect of semi-vegetarian food consumption on inflammatory markers levels including fecal calprotectin level
Fecal microbiota1 yearEffect of semi-vegetarian food consumption on changing of fecal microbiota composition and diversity (Shannon's diversity index)
Quality of life score of SIBDQ1 yearEffect of semi-vegetarian food consumption on quality of life: SIBDQ
Quality of life score of EQ5D3L1 yearEffect of semi-vegetarian food consumption on quality of life: EQ5D3L

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026